Revenue
2017
2018
2020
2021
2022
2023
2024
2025
Inmune Bio, Inc. (INMB)
Price$2.44Cached quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2017
2021
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50,000 | $14,000 | $155,000 | $374,000 | $181,000 | $11,000 | — | $0 | $0 |
| Research & development | $20.7M | $33.2M | $20.3M | $17.1M | $20.5M | $5.9M | $3.3M | $3.4M | $435,362 |
| Operating expenses | $47.4M | $42.6M | $29.9M | $26.3M | $29.3M | $12.2M | $7.8M | $12.4M | $981,480 |
| Operating income | −$47.4M | −$42.6M | −$29.7M | −$26.0M | −$29.2M | −$12.2M | −$7.8M | −$12.4M | −$981,480 |
| Operating margin | −94,766.00% | −304,535.71% | −19,187.74% | −6,938.77% | −16,106.63% | −111,163.64% | — | — | — |
| EBITDA | −$47.3M | −$42.6M | −$29.7M | −$26.0M | — | — | — | — | — |
| EBITDA margin | −94,598.00% | −304,535.71% | −19,187.74% | −6,938.77% | — | — | — | — | — |
| Net income | −$45.9M | −$42.1M | −$30.0M | −$27.3M | −$30.3M | −$12.1M | −$7.7M | −$12.4M | −$831,486 |
| Net profit margin | −91,866.00% | −300,585.71% | −19,360.00% | −7,299.20% | −16,762.43% | −109,990.91% | — | — | — |
| Basic EPSper basic share | -$1.86 | -$2.11 | -$1.67 | -$1.52 | -$1.88 | -$1.01 | -$0.75 | -$1.43 | -$0.13 |
| Diluted EPSper diluted share | -$1.86 | -$2.11 | -$1.67 | -$1.52 | -$1.88 | -$1.01 | -$0.75 | -$1.43 | -$0.13 |
Owners
Reported shareholders
≈5.62%of listed shares
Tesi Raymond Joseph1.55M shares · Sep 12, 2024
View holders
| Holder | % owned |
|---|---|
Tesi Raymond Joseph | ≈5.62%1.55M shares |
Moss David J | ≈4.65%1.29M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 2.55%706.42K shares |
AQR CAPITAL MANAGEMENT LLC | 2.39%662.22K shares |
BlackRock, Inc. | 1.13%311.61K shares |
RAYMOND JAMES FINANCIAL INC | 0.77%213K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.69%190.22K shares |
GOLDMAN SACHS GROUP INC | 0.67%185.25K shares |
MILLENNIUM MANAGEMENT LLC | 0.58%159.56K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.57%158.45K shares |
JANE STREET GROUP, LLC | 0.49%134.23K shares |
UBS Group AG | 0.40%110.41K shares |
Westside Investment Management, Inc. | 0.39%108.3K shares |
CITADEL ADVISORS LLC | 0.38%106.23K shares |
VANGUARD FIDUCIARY TRUST CO | 0.38%104.78K shares |
STATE STREET CORP | 0.34%93.36K shares |
HRT FINANCIAL LP | 0.31%84.36K shares |
IEQ CAPITAL, LLC | 0.30%82.39K shares |
GSA CAPITAL PARTNERS LLP | 0.30%81.99K shares |
Virtu Financial LLC | 0.27%75.21K shares |
Percentages use 27.65M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 30, 2024Form 4 | Moss David JChief Financial Officer | BuyCommon Stock | 10.0K | $5.29 | $52.9K | 1.29M |
| Sep 12, 2024Form 4 | Tesi Raymond JosephPresident and CEO | BuyCommon Stock | 15.4K | $6.38 | $98.1K | 1.55M |
| Sep 12, 2024Form 4 | Tesi Raymond JosephPresident and CEO | BuyCommon Stock Warrants (right to buy) · derivative | 15.4K | $0.13 | $2.0K | 15.4K |
| Sep 12, 2024Form 4 | Moss David JChief Financial Officer | BuyCommon Stock | 7.7K | $6.38 | $49.1K | 1.28M |
| Sep 12, 2024Form 4 | Moss David JChief Financial Officer | BuyCommon Stock Warrants (right to buy) · derivative | 7.7K | $0.13 | $999.70 | 7.7K |